A new meta-analysis showed that popular anemia drugs Aranesp and Procrit increase the risk of death in cancer patients by 10 percent, a statistically significant number. [NYT]
From ConsumerReports.org:
© 2005-2010 Consumer Media LLC except where noted.
Post a comment
Comments: